about
A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors.Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial CarcinomaIncreasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.Perioperative chemotherapy for muscle-invasive bladder cancer.The Rationale for Post-Operative Radiation in Localized Bladder Cancer.Prognostic value of cell-cycle regulation biomarkers in bladder cancer.Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer.C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
P2860
Q30421675-614E74B5-2057-4A01-B218-89F5647FE4CDQ30485127-DFED4008-16E9-450A-A7A1-84D5C61962BCQ35187828-DD5722CA-96A9-4FAF-854E-6389D623C01FQ35731224-DE676CA9-3C6A-420C-B361-3D3CBAFA4466Q35748060-F475E114-4A49-4219-94C7-E6E66BF929BCQ35905142-9EE6CE2D-DFF7-45C5-A700-27A0611125DAQ36314809-3E35192D-012E-40DE-B3F5-6B0A3EB3AD50Q37012561-A320FEB8-48CE-46C7-84D3-CE10E680E50EQ37053991-2783430A-E018-4863-B74B-51E467311294Q37472550-E861C69E-7FDD-4585-818C-9E2650475F7CQ37610539-89F617BD-6B3D-41B4-832A-C024ACC57BFCQ38049692-79D14157-26FA-48C6-8620-A5232EE2EDE1Q42760987-1C0409C2-4514-4A6C-998E-0306D857088EQ49526759-E480B4D6-6C0B-4E9A-A074-9D239FDAC1E7Q52588104-515E6929-3792-4DF1-8E5A-BF6CF125F0C2Q54004930-AF288683-B365-442F-8A39-D2886AE3B96CQ57545693-1033CA8C-68B6-43DF-B111-6F4B9CC267BE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Neo-adjuvant chemotherapy for invasive bladder cancer
@ast
Neo-adjuvant chemotherapy for invasive bladder cancer
@en
Neo-adjuvant chemotherapy for invasive bladder cancer
@en-gb
Neo-adjuvant chemotherapy for invasive bladder cancer
@nl
type
label
Neo-adjuvant chemotherapy for invasive bladder cancer
@ast
Neo-adjuvant chemotherapy for invasive bladder cancer
@en
Neo-adjuvant chemotherapy for invasive bladder cancer
@en-gb
Neo-adjuvant chemotherapy for invasive bladder cancer
@nl
prefLabel
Neo-adjuvant chemotherapy for invasive bladder cancer
@ast
Neo-adjuvant chemotherapy for invasive bladder cancer
@en
Neo-adjuvant chemotherapy for invasive bladder cancer
@en-gb
Neo-adjuvant chemotherapy for invasive bladder cancer
@nl
P2860
P3181
P1476
Neo-adjuvant chemotherapy for invasive bladder cancer
@en
P2860
P3181
P356
10.1002/14651858.CD005246
P577
2004-01-26T00:00:00Z